Since about two decades, emerging and re-emerging viruses have caused an increasing number of disease outbreaks in humans. In particular, emerging RNA viruses pose great threats to public health, for example, Ebola virus, Zika virus (ZIKV), and Middle-East respiratory syndrome coronavirus (MERS-CoV). The latter two are positive-sense single-stranded RNA ((+) ssRNA) viruses. We will briefly introduce the proteases of three (+)ssRNA virus families here, namely Picornaviridae, Coronaviridae, and Flaviviridae. This will be followed by a description of the complex signaling pathways that lead from recognition of the viral intruders to the production of antiviral cytokines, such as type-I and type-III interferons (IFNs). Finally, we will discuss the mechanisms by which the viral proteases interfere with these signaling pathways.
The Picornaviridae family includes a large number of small nonenveloped (+)ssRNA viruses with a genome size between 7.5 and 10 kb. As of March 2017, this family contains 35 genera with 80 species [1] . The genera Enterovirus, Hepatovirus, Aphthovirus, and Cardiovirus have been well investigated. Picornaviruses can cause several severe diseases in man and animals, such as poliomyelitis, hepatitis, and encephalitis. The viral genome usually encodes a polyprotein comprising regions P1, P2, and P3 (Fig. 1A) [2, 3] . The P1 region includes the structural proteins, while the latter two comprise nonstructural proteins, including the enzymes required for polyprotein processing and RNA replication. P1, P2, and P3 are further cleaved by viral proteases into mature proteins. P1 is digested to 1A (also known as VP4), 1B (VP2), 1C (VP3), and 1D (VP1); P2 is processed to 2A, 2B, and 2C; whereas P3 becomes 3A, 3B, 3C, and 3D [2, 3] . Picornaviruses encode up to three proteases, the 2A protease (2A pro ), the 3C protease (3C pro ), and -in case of some family members (e.g. the genera Aphthovirus and Cardiovirus) -the leader protease (L pro ) (Fig. 1A ) [4] . coronavirus PL pro feature the papain-like fold. 1) The structure of enterovirus D68 3C pro [19] (PDB entry: 3ZV8). The Ca atoms of the catalytic triad Cys-His-Glu are shown as yellow, blue, and red spheres, respectively.
2) The structure of transmissible gastroenteritis virus (TGEV, a CoV) 3CL
pro (M pro The Coronaviridae family is divided into two subfamilies, Coronavirinae and Torovirinae [1] . Two recently emerged human coronaviruses from the subfamily Coronavirinae, severe acute respiratory syndrome coronavirus (SARS-CoV) and MERS-CoV, can cause severe pneumonia. In particular, the latter virus frequently also leads to renal failure [5] . Coronaviruses are enveloped +ssRNA viruses and have the largest genome (26-32 kb) of all known RNA viruses. The 5 0 -terminal two thirds of the genome contain the two open-reading frames (ORFs) 1a and 1b. ORF1a codes for polyprotein 1a containing nonstructural protein 1-11 (Nsp1-11), while ORF1a and ORF1b together encode polyprotein 1ab comprising Nsp1-16. This latter mechanism features a (-1) ribosomal frameshift overreading the stop codon of ORF1a (Fig. 1A) [6] . The 3 0 -proximal third encodes the structural and accessory proteins [7, 8] . These two polyproteins are processed into 15 or 16 mature Nsps to form the replication/transcription complex. This step is performed by two types of viral proteases, namely, one or two papain-like proteases (PL pro (s)) located within Nsp3, and a main protease (M pro ) (Nsp5), which is frequently also called '3C-like protease' (3CL pro ) ( Fig. 1A ; see [9] for a review). The family Flaviviridae includes four genera: Hepacivirus, Flavivirus, Pestivirus, and Pegivirus. Here, we discuss viral proteases from the former three genera. Since the genome organization and the proteases are different in these three genera of the Flaviviridae family, we will introduce them separately.
Viruses from the genus Hepacivirus are enveloped (+) ssRNA viruses. The best characterized member of this genus is hepatitis C virus (HCV). This virus can lead to acute and chronic hepatitis. About 71 million people have chronic hepatitis C infection worldwide (www. who.int, last accessed on August 16, 2017) . The genome of HCV is about 9.6 kb in size and encodes a polyprotein precursor that is processed by host and two viral proteases to yield four structural (C, E1, E2, and p7) and six nonstructural proteins (NS2, NS3, NS4A, NS4B, NS5A, and NS5B). These two viral proteases are the NS2 autoprotease (NS2 pro ) and the NS3/NS4A protease (NS3/NS4A pro ) [10, 11] . NS4A is a cofactor for the NS3 protease. In HCV, the latter enzyme is also called NS3/4A pro in many publications; however, we will use 'NS3/NS4A
pro ' in what follows, in order to be consistent with the NS2B/NS3 pro notation in the flaviviruses. Viruses of the genus Flavivirus are also enveloped (+) ssRNA viruses. Members of the genus include dengue virus (DENV), West Nile virus (WNV), yellow fever virus (YFV), tick-borne encephalitis virus (TBEV), Zika virus (ZIKV), etc. Flaviviruses are mainly transmitted by arthropods, such as mosquitoes or ticks. Many of the mosquito-borne family members are highly endemic in the tropics and subtropics, whereas TBEV is prevalent in Central and Eastern Europe. The~11-kb genome of flaviviruses encodes a polyprotein that is cleaved into three structural (C, prM, and E) and seven nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) by host and viral proteases (Fig. 1A) . The genus Flavivirus only has one protease, NS2B/NS3 pro [12] . Viruses of the genus Pestivirus mainly infect mammals, such as cattle and swine. Bovine viral diarrhea virus (BVDV) and classical swine fever virus (CSFV) belong to this genus. The genome of pestiviruses encodes a polyprotein that is processed by viral and host proteases into 12 mature proteins (N pro , C, E rns , E1, E2, p7, NS2, NS3, NS4A, NS4B, NS5A, and NS5B). In this genus, three proteolytic enzymes, the N-terminal protease (N pro ), the NS2 pro , and the NS3/ NS4A pro , have been identified [13] [14] [15] . Although the primary structures of proteases in these three (+)ssRNA virus families are very different from one another, the three-dimensional structures of most proteases belong to either the chymotrypsin-like fold or the papain-like fold (Fig. 1B) . The typical chymotrypsin fold consists of two b-barrel domains, each containing six b-strands. The catalytic residues are located in the cleft between these two domains. Picornavirus 2A pro [16] , 3C
pro [17] [18] [19] , HCV NS3/NS4A pro [20] , flavivirus NS2B/ NS3 pro [21, 22] , and pestivirus NS3/NS4A pro [23] adopt this fold; however, the former two enzymes are cysteine proteases, while the latter three are serine proteases. The coronavirus M pro (3CL pro ) also possesses a chymotrypsin-like fold, but with an additional a-helical domain; furthermore, dimerization of this cysteine protease is a prerequisite for its activity (Fig. 2B) [9, 24] . However, the picornavirus L pro [4, 25] and the coronavirus PL pro [9, 26, 27 ] feature a papain-like fold. The canonical papain-like fold contains an a-helical and a predominantly b-sheet domain, with the active site located in the cleft between them. This is exactly what is found in the picornavirus L pro [4, 25] , whereas in the coronavirus PL pro , the b-sheet domain is larger and further divided into two subdomains: fingers and palm. Together with the thumb subdomain (a-helical domain), they form an extended right-hand fold. In addition, a ubiquitin-like (Ubl) domain is located at the N terminus of the PL pro (Fig. 1B) [9, 26, 27] .
The various pathways to interferon expression in the host innate immune system Viral infection will trigger immune responses. The host immune system consists of innate and adaptive 
Toll-like receptors (TLRs)
TLRs are transmembrane glycoprotein receptors. Different TLRs can be localized to the surface of the cell or to intracellular endosomes as well as lysosomes; therefore, they can detect various pathogens outside and inside of host cells [37, 38] . TLRs comprise three subdomains: the N-terminal PAMP-binding region (PBR), which includes multiple leucine-rich repeats (LRRs), the middle transmembrane domain, and the C-terminal Toll/IL-1R homology (TIR) domain ( Fig. 3) [38]. The N-terminal domain is used to bind PAMPs, while the C-terminal domain is involved in initiating the signaling cascades. In man, a total of 10 TLRs have been characterized [39] . TLR3, 7, 8 detect various RNA viruses and TLR9 detects DNA viruses [37]; in particular, TLR3 is mainly responsible for recognizing dsRNA while TLR7 detects ssRNA [33, 37] . However, TLR3 and TLR7 utilize different downstream adaptors to activate the IRF3/7 or the NF-jB signaling pathway.
The TLR3 signaling pathway
When binding dsRNA, TLR3 dimerizes [38, 40] . The C-terminal TIR domains of dimeric TLR3 interact with the adaptor TRIF (TIR domain-containing adaptor protein-inducing IFNb) [41] . TRIF, in turn, recruits Lys63-linked polyubiquitinated TRAF6 (TNF receptor-associated factor 6), thereby leading to the Lys63-linked polyubiquitination of TAK1 (TGF-b activated kinase 1); TAK1 further recruits TAB 1/2/3 (TAK1-binding protein 1/2/3), thus yielding the quaternary TAK1/TAB 1/TAB 2/TAB 3 complex, which activates IKKa/b/c (IjB kinase alpha, beta and gamma; IKKc is also known as NEMO, NF-jB essential modulator) [42] [43] [44] [45] . Subsequently, the IKKs mediate the phosphorylation and degradation of the NF- jB inhibitor, IjB. Without IjB binding, NF-jB will enter the nucleus and trigger the expression of inflammatory genes ( Fig. 2A) .
Also, TRIF can interact with TRAF3 modified by Lys63-linked polyubiquitination, in order to further recruit TBK1 (TANK-binding kinase 1) and IKKe (IjB kinase epsilon) [41, 46] . IKKc (NEMO) is also involved in activating TBK1 and IKKe ( Fig. 2A) [47] . The activated TBK1/IKKe will phosphorylate IRF3 [48, 49] , thereby inducing IRF3 dimerization and nuclear translocation to trigger type-I (mainly IFNb) and type-III IFN production ( Fig. 2A) . Subsequently, the expression of IRF7 is upregulated. TBK1/IKKe also phosphorylates IRF7 [49] , the activated IRF7 can stimulate the release of various IFNs ( Fig. 2A) .
The TLR7 signaling pathway
Upon PAMP binding, TLR7 recruits the adaptor MyD88 (myeloid differentiation primary response gene 88) [50] . Next, MyD88 forms a complex with interleukin-1 receptor-associated kinases (IRAKs) (such as IRAK4, IRAK1, and IRAK2) [37, 51] . Subsequently, IRAK4 activates IRAK1/2 and then IRAKs dissociate from upstream MyD88 and interact with downstream TRAF6 [51] , further activating the NF-jB signaling pathway as described above ( Fig. 2A) . Meanwhile, multiple proteins, TRAF6, TRAF3, IRAK4, IRAK1, and IKKa can form a complex for signaling. When contacting this complex, IRF7 is phosphorylated by both IRAK1 and IKKa, thus activating the downstream signaling [37, 51] .
RIG-I-like receptors (RLRs)
Currently, RLRs comprise three cytosolic proteins: RIG-I [52] , melanoma differentiation-associated antigen 5 (MDA5) [53] , and 'laboratory of genetics and physiology 2' (LGP2) [54] . RIG-I and MDA5 each contain two N-terminal cysteine-aspartic protease (caspase)-recruiting subdomains (CARDs), a central DExD/H helicase domain, as well as the C-terminal repressor domain (RD) (Fig. 3) . In contrast, LGP2 lacks the CARDs domain.
The helicase and RD domains of the RLRs are involved in recognizing the dsRNA of RNA viruses [52] , while the CARD subdomains lead to intracellular signaling events [31, 52] . Due to the absence of CARDs, LGP2 plays a role in regulating RIG-I and MDA5 signaling. Interestingly, LGP2 is a negative regulator of RIG-I signaling [54, 55] , while it acts a positive regulator facilitating MDA5 binding to viral RNA, thereby augmenting the MDA5 signaling pathway [56, 57] . RIG-I preferentially binds short dsRNA (< 1 kb), while MDA5 binds long dsRNA (> 2 kb) [31] . Furthermore, RIG-I is critical for detecting paramyxoviruses, influenza virus, and Japanese encephalitis virus (JEV), whereas MDA5 recognizes mainly picornaviruses as well as HCV [58, 59] .
When RIG-I binds the PAMPs, the CARDs domain is exposed to interact with the CARD domain of MAVS (mitochondrial antiviral-signaling protein; also known as IPS-1, Cardif, VISA), which is localized to the membrane of mitochondria [60] . Also, MAVS forms oligomers via its CARD domain, a process that is necessary for downstream signaling [61] . At the same time, RIG-I binding to MAVS is promoted by ubiquitination through TRIM25 [62] . The RIG-I-MAVS interaction stimulates TRAF3 and TRAF6 [63, 64] . Subsequently, the signals are transduced by the downstream complexes TBK1-IKKe and IKKa/b/c to further induce the activation of the IRF3 and NF-jB pathways, respectively, similarly to the downstream signaling pathway of TLR3 mentioned above ( Fig. 2A) . Finally, these signals trigger the production of IFNs and other host cytokines.
NOD-like receptors (NLRs)
NOD-like receptors are cytosolic proteins. They are activated in response to PAMPs in the cytosol ( Fig. 2A) . The members of the NLR family have various domain architectures [65] . However, they contain three common subdomains: (a) the N-terminal effectorbinding domain (EFB), for example, a CARD domain, a pyrin domain (PYD), or a baculovirus inhibitor of apoptosis protein repeat (BIR) domain; (b) the middle NACHT domain (exists in NAIP, CIITA, HET-E, and TP-1); (c) the C-terminal LRR domain (Fig. 3) . According to the different N-terminal domains, the NLRs are divided into five families: NLRA (N-terminal acidic activation domain), NLRB (N-terminal BIR domain), NLRC (N-terminal CARD domain), NLRP (N-terminal PYD domain), and NLRX (N-terminal unknown domain) [65] . Here, we discuss two well-characterized NLRs, NLRP3 and NLRC2, that regulate host immune responses during viral infection.
NLRP3 is sensitive to infection by several (À) ssRNA and (+)ssRNA viruses, such as influenza A virus (IAV), vesicular stomatitis virus (VSV), encephalomyocarditis virus (EMCV), and HCV [66] [67] [68] . When NLRP3 is activated by PAMPs derived from invasive viruses, oligomeric NLRP3s interact with ASC (apoptosis-associated speck-like protein) and procaspase-1 ( Fig. 2A) . They form an inflammasome complex, which results in the activation of caspase-1, thus leading to the maturation of pro-IL-1b and pro-IL-18 ( Fig. 2A) [36, [66] [67] [68] . However, so far, there is no evidence for NLRP3 directly binding virus ssRNA or dsRNA. NLRP3 inflammasome activation relies on lysosomal maturation and the production of reactive oxygen species (ROS) during IAV infection [66] ; therefore, NLRP3 is likely activated by intracellular changes (such as lysosomal maturation and ROS formation) but not directly by interaction with PAMPs [33, 36] .
NLRC2 (alternatively named NOD2), as an intracellular innate immune sensor, recognizes bacterial MDP (muramyl dipeptide) to regulate the host immune response [69] . It also recognizes the RNA of several (À)ssRNA viruses, such as IAV, VSV, and respiratory syncytial virus (RSV) [70] . NLRC2 directly interacts with viral ssRNA and recruits MAVS to activate the IRF3 pathway, thereby releasing the type-I IFN, IFNb [70] . NLRC2 can also activate TRAF6 and stimulate the NF-jB pathway [71] .
RNA-virus proteases interfering with the host innate immune response
Viral proteases are not only important for processing the polyproteins in (+)ssRNA viruses but are also involved in counteracting the host innate immune response. In this review, we focus on the viral proteases of three RNA virus families (Picornaviridae, Coronaviridae, and Flaviviridae) and discuss how they antagonize the host's antiviral response.
The 2A and 3C proteases of Picornaviridae
Two viral proteases, the 2A pro and the 3C pro , are required for processing the polyprotein in the viral life cycle [4] . However, several picornaviruses, such as Footand-Mouth disease virus (FMDV), have yet another protease, the L pro [4] . Interestingly, hepatitis A virus (HAV) has exclusively the 3C protease [72] , whereas the 2A protein is part of the virion [73] . Picornaviruses are detected by RLRs, mainly by MDA5, as well as by TLRs [74, 75] . It is no surprise that picornaviruses have evolved efficient ways to inhibit the antiviral type-I IFN production. In particular, the 2A pro and the 3C pro can disrupt the RLR-or TLR-mediated innate immune pathways. We will discuss further below how the L pro counteracts the host innate immune response.
2A pro antagonizes the host immune response
The members of the genus Enterovirus of the Picornaviridae family have been well investigated regarding the mechanism of innate immunity disruption by the 2A pro [76] [77] [78] . The enteroviral 2A pro possesses a Cys-His-Asp catalytic triad [16] . It cleaves between P1 and P2, that is, the site between the capsid and nonstructural-protein precursors, which is an essential event in the enterovirus life cycle [4] . 
3C
pro antagonizes the host immune response
The 3C pro has either a catalytic Cys-His dyad or a Cys-His-Asp/Glu triad in different picornaviruses (Fig. 1B) [17] [18] [19] . The protease prefers to cleave between Gln and Gly (and sometimes, between Glu and Gly) [88] . Besides viral polyprotein processing, this protease also has an RNA-binding activity being essential for viral RNA replication [89] . Currently, Michael-acceptor compounds such as rupintrivir and SG85 have been described as potent, broad-spectrum inhibitors of enterovirus 3C proteases [19, 90, 91] . pro needs to be further investigated; in any case, the partly conflicting observations mentioned above indicate that RIG-I is an important target antagonized by the picornavirus 3C
pro . Like RIG-I, MDA5 binds MAVS to activate downstream cascades of the innate immune system (see above). Lei et al. [92] found by co-immunoprecipitation (co-IP) that EV-A71 3C pro can bind MDA5 ( Fig.  2A) pro was also shown to induce cleavage of MAVS at the same position, Gln148↓Ala149 (↓: cleavage site) [96] . Therefore, both viruses suppress the antiviral IFN production through cleavage of MAVS.
pro cleaves TRIF
The picornavirus 3C pro can also interfere with the TLR3 pathway. As mentioned above, the C-terminal TIR domains of dimeric TLR3 interact with TRIF to stimulate the downstream IRF3 and NF-jB activities. CVB3 3C pro was demonstrated to cleave TRIF ( Fig. 2A) , thereby blocking the downstream type-I IFN production in CVB3-infected cells [81] . In total, five cleavage sites in TRIF (Gln190↓Gly191, Gln653↓Ser654, Gln659↓Ser660, Gln672↓Ser673, and Gln702↓Ala703) were found [81] . Furthermore, the 3C pro of EV-A71 or EV-D68 can also cleave TRIF, leading to inactivation of the signaling along the IRF3 and NF-jB pathways in vivo [97, 98] . However, the EV-A71 3C pro processes only one site between Gln312 and Ser313, while the EV-D68 protease cleaves two sites (Gln312↓Ser313, Gln653↓Ser654) [97,98]. It seems that the different 3C pro s possess slightly different cleavage patterns on TRIF. Whether these subtleties are linked to any difference in biological response needs to be answered. Similarly to the 3ABC precursor digesting MAVS (see above), the HAV protease can also cleave TRIF in vivo [99], but the degradation appears to be exclusively performed by the 3CD (protease-polymerase precursor) protein, not by mature 3C protease alone. The two cleavage sites in TRIF are Gln190↓Gly191 and Gln554↓His555 [99] . The observation that some precursor proteins (such as HAV 3ABC, 3CD) seem to be involved in counteracting the host immune response should motivate further investigations into more protease precursors, instead of looking only into mature proteases.
pro cleaves IKKc (also named NEMO)
The FMDV 3C pro can process the porcine IKKc (also called NEMO) at the unusual cleavage site Gln384↓Arg385, thereby removing the C-terminal zinc- pro processes TANK to stimulate the NFjB pathway but downregulate the IRF3 pathway. Very recently, Qian et al. [96] showed that the SVV 3C pro processes TANK at two cleavage sites, Glu272↓Phe273 and Gln291↓Gly292. Whereas the former site is unusual because of the large P1' residue, the latter is also cleaved by the EMCV 3C pro , indicating that it may be a conserved target on TANK for different picornavirus 3C pro s.
pro cleaves TAK1/TAB 1/TAB 2/TAB 3
The EV-A71 3C pro uses another mechanism to deactivate the NF-jB pathway. As mentioned above, TAK1 can bind TAB 1 to form a complex [42] . This complex recruits TAB 2 and TAB 3, yielding the quaternary TAK1/TAB 1/ TAB 2/TAB 3 [43, 44] . The combination of TAK1 and TABs can activate IKKs (such as IKKa, IKKb, and IKKc) [45] , thereby upregulating the NF-jB pathway. The EV-A71 3C pro cleaves TAK1 (Gln360↓Ser361), TAB 1 (Gln414↓Gly415 and Gln451↓Ser452), TAB 2 (Gln113↓Ser114), and TAB 3 (Gln173↓Gly174 and Gln343↓Gly344) in vivo ( Fig. 2A) [108] . Recently, the CV-A16, CV-A6, and EV-D68 3C pro s have also been shown to process TAK1 [94] . In summary, the enterovirus 3C pro impairs NF-jB activation.
pro cleaves IRFs IRF7 stimulates type-I IFN production, such as IFNa, thereby activating the JAK-STAT pathway in adjacent cells [109] . The 3C pro of EV-A71 can process IRF7 at a cleavage site between Gln189 and Ser190 in vitro and in vivo, while the 3C pro of EV-D68 does so at two sites (Gln167↓Ala168 and Gln180↓S190) [110, 111] .
Furthermore, IRF9 interacts with STAT1 and STAT2 to form a complex, ISGF3 in the JAK-STAT pathway, thereby stimulating ISG production (Fig. 2B) Fig. 2A) , thus disrupting the expression of IFN and ISGs [120] .
Furthermore, the FMDV Lb pro exhibits deubiquitinating activity [121] ; it can remove Lys48-and Lys63-linked polyubiquitin in vitro and in vivo. As mentioned above, the ubiquitination of several elements is essential in innate immune pathways, for example, of RIG-I, TRAF3, and TRAF6 [62, 104, 122] . Wang et al. [121] reported that the FMDV Lb pro can deubiquitinate RIG-I, TBK1, TRAF3, and TRAF6 in HEK293T cells overexpressing this protease, which leads to blocking type-I IFN production.
Like the 2A pro , the L pro can also cleave eIF4G to globally inhibit the translation of mRNAs coding for host antiviral proteins [25, 87] .
Many investigations have shown that the papain-like proteases of coronaviruses also possess DUB activity relevant for antagonizing the host innate immune response; these enzymes are discussed in the next paragraph.
Papain-like proteases and 3C-like proteases of the Coronaviridae interfere with innate immunity
Belonging to the family Coronaviridae, coronaviruses have one or two viral PL pro (s) and one 3CL pro (M pro ) [9] . The PL pro (s) is (are) part of the nonstructural protein 3 (Nsp3) [123, 124] . PL pro is a cysteine protease with a catalytic triad Cys-His-Asp (Fig. 1B) [26]. The CoV PL pro has proteolytic, deubiquitinating, and deISGylating (removal of ISG15 from target proteins) activities [26, 27, 125] ; through the latter two, it can disrupt the host immune response. Thus far, only a few inhibitors targeting the PL pro have been described. B aez-Santos et al. [126] demonstrated that several naphthalene derivatives efficiently block the enzymatic activity of SARS-CoV PL pro .
PL
pro modulates the TLR7 pathway by deubiquitinating TRAF3 and TRAF6
As mentioned above, TLR7 recognizes ssRNA [33, 37] . In 2013, Li et al. [127] showed that GU-rich ssRNA of SARS-CoV can be detected by TLR7.
The SARS-CoV PL pro removes Lys63-linked ubiquitin (Ub) chains from TRAF3 and TRAF6 to reduce the TLR7-mediated immune signaling [128] . Furthermore, the SARS-CoV PL pro cannot remove Lys48-linked Ub chains from TRAF3 and TRAF6 according to a western blot assay [128] . This is at variance with an in vitro study that demonstrated that SARS-CoV PL pro prefers to process Lys48-over Lys63-linked polyUb chains [129] . Perhaps, one might speculate that the target proteins, TRAF3 or TRAF6, affect the PL pro DUB specificity.
In addition, TRAF3 and TRAF6 are two key components of the RLR pathways (Fig. 2A) ; therefore, we have reason to believe that PL pro could also regulate RLR signaling by deubiquitinating these two targets.
pro modulates the STING-TRAF3-TBK1-IKKe complex STING (stimulator of IFN genes, also known as MITA, ERIS) is a protein of the endoplasmic-reticulum (ER) (Fig. 2A) . It can activate the IRF3 pathway upon dimerization and ubiquitination as well as upon interaction with several partners, such as MAVS, TRAF3, TBK1, and IKKe [130, 131] . The SARS-CoV PL pro +TM (TM: transmembrane region of Nsp3; see Ref. [124] for a review) and Human Coronavirus-NL63 (HCoV-NL63) PL2 pro +TM bind STING in a co-IP assay [132] . These two proteins inhibit the dimerization and ubiquitination of STING and disrupt STING interaction with other partners, thereby blocking STING-mediated IFN production. Interestingly, the enzymatic activity of SARS-CoV PL pro +TM or HCoV-NL63 PL2 pro +TM is not required for modulating STING [132] .
Furthermore, SARS-CoV PL pro +TM can disrupt the STING-TRAF3-TBK1-IKKe complex by binding each of its components [133] . In addition, the SARSCoV PL pro +TM or PL pro alone were also reported to bind IRF3 [133, 134] . Meanwhile, SARS-CoV PL pro reduces the ubiquitination of STING, TRAF3, and TBK1 [133] . Also, murine hepatitis virus A59 (MHV-A59) PL2
pro deubiquitinates TBK1 and binds TBK1 and IRF3 [135, 136] . All these observations demonstrate that the PL pro is heavily involved in regulating the IRF3 pathway.
PL pro blocks the p53-IRF7-IFNb pathway
The tumor suppressor protein p53 enhances the antiviral type-I IFN response [137] . In 2015, Yuan et al. [138] found that p53 can upregulate the transcription of IRF7. HCoV-NL63 PL2 pro deubiquitinates and stabilizes MDM2, a p53 degradation stimulator, thus causing p53 degradation and blocking the p53-IRF7-IFNb signaling pathway ( Fig. 2A) [138] . p53 also inhibits SARS-CoV replication [139] . Ma-Lauer et al. [139] found that the PL pro s of SARS-CoV and MERS-CoV as well as the two PL pro s of HCoV NL63 can bind RCHY1, another p53-degradation stimulator. The SARS-CoV 'unique domain' (SUD) enhances the interaction between the PL pro and RCHY1. This interaction increases the stability of RCHY1, thereby stimulating p53 degradation [139] . In conclusion, the coronavirus PL pro utilizes various ways to modulate p53 and further regulate host innate immunity responses.
PL pro blocks the NF-jB pathway
Besides blocking the IRF3 pathway, Frieman et al. [140] reported that the SARS-CoV PL pro stabilizes IjBa, an inhibitor of NF-jB, to modulate the NF-jB signaling pathway. Further, these workers found that the HCoV-NL63 but not the MHV PL2 pro can counteract the IRF3 and NF-jB pathways [140] . These observations indicate that the functions of the PL pro could be specific for different CoVs.
Furthermore, Devaraj et al. [134] indicated that the protease activity of the SARS-CoV PL pro is not required for blocking IFNb production. Frieman et al. [140] reported that the enzyme activity of SARS-CoV PL pro is dispensable for IFNb production via the IRF3 pathway but not for TNFa production through the NFjB pathway. In 2010, Clementz et al. [141] also found that the catalytic activity of the HCoV-NL63 PL2 pro is not responsible for blocking IFNb production. In contrast, the MHV PL2 pro requires the enzymatic activity for blocking IFNb induction [136] . The exact relationship between the enzymatic activity of the PL pro and IFN production is still a matter of debate today.
Other roles of the PL pro in counteracting host immunity
The PL pro has deISG15ylating activity (Fig. 2B ) [125] , leading to the downregulation of the host immune response. However, the detailed mechanism of this process is still not completely clear. In addition, autophagy could play a negative role in the host innate immune response [142] . Chen et al. [143] found that the PL pro +TM of SARS-CoV induces incomplete autophagy by interacting with LC3 and Beclin1 (two key autophagy regulators), thus negatively regulating antiviral immunity. Knockdown of Beclin1 could partially reverse the effect of the PL pro on innate immune signaling [143] . Therefore, these authors assume that the PL pro +TM inducing autophagy could represent a new mechanism of antagonism to host innate immunity by coronaviruses.
3CL
pro antagonizes host immune responses
The 3CL pro (M pro ), the other protease of coronaviruses, is also involved in counteracting the host innate immune response. A number of peptidic and peptidomimetic inhibitors carrying various warheads have been described to block the activity of the coronavirus M pro ([144] ; see Refs [9, 145] for reviews).
The M pro s of two CoVs infecting pigs have recently been reported to antagonize the host immune response (Fig. 2) [146] [147] [148] . The M pro s of both porcine epidemic diarrhea virus (PEDV, a member of the genus Alphacoronavirus) and porcine deltacoronavirus (PDCoV) cleave porcine IKKc (NEMO) at the identical site, Gln231↓Val232 [146, 147] . As mentioned above, NEMO is required for activating the NF-jB and IRF3 pathways. Therefore, the cleavage of IKKc by PEDV and PDCoV M pro s abrogates NF-jB signaling and inhibits IFNb induction [146, 147] . In addition, the M pro of PDCoV can process porcine STAT2 at two sites, Gln685↓Glu686 and Gln758↓Ser759, to impair the JAK-STAT pathway [148] , thereby reducing ISG production. It is interesting to investigate whether the human CoV M pro exhibits similar activities to affect the host innate immune response.
Proteases of Flaviviridae interfering with the innate immune response
In the following paragraphs, we will discuss the proteases of the genera Hepacivirus, Flavivirus, and Pestivirus of the Flaviviridae family.
HCV NS3/NS4A protease counteracts host innate immune pathways
The best known member of the genus Hepacivirus is HCV. HCV produces two proteases, NS2
pro and NS3/ NS4A pro [10, 11] . The autoprotease NS2 pro operates only on one cleavage site, between NS2 and NS3, while the other cleavage sites among the NS proteins of HCV are processed by the NS3/NS4A pro [11] . Currently, the NS3/NS4A
pro , but not the NS2 pro , is reported to be related to counteracting host innate immune responses (Fig. 2A) . The former enzyme features the catalytic triad Ser-His-Asp [20] . The cleavage site specificity of the NS3/NS4A pro favors Cys or Thr in the P1 position, an acidic residue in the P6 position, and a residue with a small side-chain (Ala or Ser) in P1 0 , that is, D/E-XXXX-C/T-S/A for the P6-P1 0 sequence [11] . NS4A is a cofactor for the NS3 protease. Several synthetic inhibitors of the HCV NS3/ NS4A pro , such as simeprevir and paritaprevir (ABT-450), have helped to dramatically improve the therapy of liver disease caused by HCV [149, 150] .
HCV NS3/NS4A pro cleaves MAVS
In 2005, RIG-I was shown to detect the 3 0 UTR (untranslated region) of the HCV genome [151] . However, later Cao et al. [59] demonstrated that MDA5 plays a major role in recognizing the 3 0 UTR of HCV while RIG-I seems to be less important. Subsequently, MDA5 (or RIG-I) binds MAVS, thereby activating the downstream IRF3 and NF-jB pathways. HCV NS3/ NS4A pro cleaves MAVS (also named Cardif, as mentioned above; Fig. 2A) at the cleavage site Cys508↓His509 [152] , thereby disrupting the host immune response. The NS3/NS4A pro of GB virus B (GBV-B) , from the same genus as HCV, cleaves MAVS at the same site as the HCV enzyme [153] . These authors further found that MAVS was released from the mitochondrial membrane to the cytosol due to this cleavage [153] . Because the location of MAVS on the mitochondrial membrane is essential for its functions, this observation could explain how MAVS fails to transmit the signal downstream after being processed by NS3/NS4A
pro [153] . Furthermore, NS3/NS4A proteases from Hepaciviruses infecting other animals (such as monkeys, rodents, horses, and cows) can cleave their cognate MAVS proteins [154] . The cleavage of MAVS presents a common mechanism used by Hepaciviruses to regulate the host immune response.
NS3/NS4A
pro cleaves Riplet (upstream regulator of RIG-I)
As mentioned above, RIG-I is ubiquitinated by TRIM25 for its activation [62] . Oshiumi et al. [155] reported that the protein Riplet (an E3 ubiquitin ligase) is a prerequisite for TRIM25 stimulation of RIG-I signaling. Knocking out Riplet abrogates the expression of type-I IFN in response to HCV RNA [155] . HCV NS3/ NS4A pro can cleave Riplet at position Cys21↓Ile22 in vitro, because the residues 16-EDDLGC-21 of Riplet are similar to the consensus cleavage motif D/E-XXXX-C/T of HCV NS3/NS4A protease. As a consequence, RIG-I activation is abolished [155] .
pro modulates TRIF of the TLR3 pathway TLR3 is sensitive to the intermediate dsRNA of HCV replication [156] . Upon sensitization, its C-terminal TIR domain can interact with TRIF to stimulate the downstream cascades. HCV NS3/NS4A pro cleaves TRIF at the site Cys372↓Ser373 in vitro and in vivo (HEK293 cells) to disrupt the TLR3 pathway [157] . In contrast to this observation, Dansako et al. [158] found that HCV NS3/NS4A cannot cleave TRIF in PH5CH8 (immortalized human hepatocytes), HeLa, and Huh-7-derived cells. The effects of the NS3/NS4A protease on TRIF need to be further investigated, in order to resolve this ambiguity.
pro modulates importin b1
Very recently, Gagn e et al. [159] found that the HCV NS3/NS4A pro can cleave importin b1 (IMPb1; Fig.  2A ). IMPb1, a nucleocytoplasmic transport receptor, transports proteins from the cytoplasm to the nucleus. The HCV NS3/NS4A protease triggers the degradation of IMPb1 and inhibits or disrupts the nucleocytoplasmic trafficking of IRF3 as well as NF-jB p65, thus preventing the host immune response [159] .
Flavivirus NS2B/NS3 proteases counteracting host innate immune pathways
Flaviviruses only have one protease, the NS2B/NS3 pro [12] . This enzyme comprises the N-terminal third of NS3 and the middle hydrophilic part of NS2B as a cofactor, together forming the NS2B/NS3 pro . Like HCV NS3/NS4A pro , the flavivirus NS2B/NS3 pro is a chymotrypsin-like serine protease with a catalytic SerHis-Asp triad (Fig. 1B) [21, 22] . The P1 and P2 positions at the NS2B/NS3
pro cleavage sites are conserved as basic residues, Lys or Arg. The NS2B/NS3
pro is an attractive antiviral target. This protease is also involved in counteracting host innate immune pathways ( Fig. 2A) . Currently, no approved drug is available that targets the flavivirus NS2B/NS3 pro . Several peptide aldehydes and peptide boronic-acid inhibitors have been described to inhibit the activity of the flavivirus NS2B/NS3
pro [22, [160] [161] [162] .
The NS2B/NS3 pro cleaves STING As mentioned above, STING can upregulate IRF3 signaling ( Fig. 2A ) [130, 131] . DENV NS2B/NS3 pro cleaves human STING at the site Arg94-Arg95↓Gly96 in vivo and thereby inhibits induction of IFNb [163, 164] . However, this protease is unable to cleave RIG-I, TLR3, TBK1, IKKe, IRF3, and IRF7 [163] . Recently, Liu et al. [165] reported that the full-length DENV NS3 (including the C-terminal helicase), but not the NS2B, can be modified by Lys27-linked polyubiquitination when co-transfecting Ub and NS3 in HEK 293T cells. The ubiquitinated NS3 facilitates recruitment of NS2B, that is, the formation of the NS2B/NS3 protease, thereby enhancing the cleavage of STING. Furthermore, these authors found that the ER protein SCAP (sterol regulatory element-binding protein (SREBP) cleavage-activating protein) can bind NS2B and inhibit polyubiquitination of NS3, thus disrupting the formation of NS2B/NS3 pro and the cleavage of STING [165] .
The NS2B/NS3 protease cleaves two mitofusins (MFN1, MFN2) MFN1 and MFN2 regulate the mitochondrial fusion; in particular, MFN1 is required for the RLR signaling pathway [166] . Yu et al. [167] demonstrated that the DENV NS2B/NS3 protease can cleave MFN1 (Arg539-Asn540↓Ala541) and MFN2 (Arg563-Arg564↓Ala565) in cells. Subsequently, the cleaved MFNs suppress mitochondrial fusion and disrupt IFN production. Interestingly, the homologous protease from JEV cannot cleave MFNs for unknown reasons [167] . It is worth investigating whether or not other flavivirus proteases modulate MFNs.
Pestivirus N-terminal protease counteracts host immune responses
As mentioned above, a total of three proteases -N pro , NS2 pro , and NS3/NS4A pro -are encoded by the pestivirus genome. To our knowledge, only the N pro is reported to be involved in counteracting the host innate immune pathways (Fig. 2A) ; therefore, we will restrict ourselves to discussing this enzyme here. The pestivirus N pro is cleaved off the polyprotein by autolysis between C (the capsid protein) and the N pro [14] . It is a cysteine protease with a catalytic dyad Cys-His. The N pro adopts neither a chymotrypsin-like nor a papain-like fold. Instead, it features a unique 'clam-like' fold containing a catalytic protease domain and a zinc-binding domain [168] . After autocleavage, the N pro loses its cleavage capability by intramolecular auto-inhibition [168] . N pro binds IRF3 and IRF7
The N pro s of CSFV and BVDV directly bind IRF3 and induce degradation of the factor by the host proteasome, thus interfering with IFN production [169] [170] [171] [172] . According to point mutation experiments, both the protease domain and the zinc-binding domain are essential for N pro binding to IRF3 [168, 173, 174] . Furthermore, the CSFV N pro can also bind IRF7 and downregulate the IRF7 protein level in porcine DC cells, thus limiting type-I IFN production [175] . Also, Fiebach et al. [175] found that the zinc-binding domain but not the protease domain is required to bind IRF7. N pro interacts with IjBa (NF-jB inhibitor)
The CSFV N pro binds IjBa in vitro and in vivo [176] . However, the enzyme does not affect the NF-jB activity [176] . The BVDV N pro cannot block the NF-jB pathway either [171] . The role of the N pro -IjBa interaction, thus, remains unclear for the time being.
Conclusions
The proteases of emerging or re-emerging (+)ssRNA viruses are always worth investigating, either as targets for direct antivirals disrupting polyprotein processing [9, 162, 177] or as important players in mounting the viral anti-IFN activity. In this review, we discussed the roles of viral proteases from the families Picornaviridae, Coronaviridae, and Flaviviridae in counteracting host innate immune responses. Among the different PRR-mediated signaling pathways, a large body of data is available for components of the RLR and TLR pathways being cleaved by viral proteases, but much less so for the NLR pathway (with the notable exception of MAVS in the NLRC2 pathway as a prominent target of viral proteases). A possible reason for this could be that at this time, many immunity-related functional roles of NLRs remain unclear. Another observation is that a multitude of reports exist on the proteolytic cleavage of components of the innate immune system by the picornaviral 2A pro and 3C pro as well as the HCV NS3/NS4A pro , while proteolytic cleavage by the coronavirus proteases PL pro and 3CL pro (M pro ) seems to be comparatively rare. This may be due to more research having been performed on the picornaviruses and on HCV, or to the fact that the DUB activity of the coronavirus PL pro (as opposed to its proteolytic activity) is a very efficient player in counteracting the innate immune response. Furthermore, it should be remembered that CoVs feature many other proteins (such as ORF3b, ORF6, the nucleocapsid protein, the membrane protein, and the X domain in SARS-CoV; ORF4a, ORF4b, ORF5, and the membrane protein in MERS-CoV) that are involved in suppressing IFN production [124, 178] , so proteolytic cleavage of host immunity proteins is perhaps required to a lesser extent here. For picornaviruses and HCV on the other hand, there is only occasional reports on nonproteases, such as the picornaviral 2C and 3A proteins [179, 180] as well as HCV NS5A and E2 [181, 182] , being involved in diminishing cytokine production.
In general, homologous proteases from the same family show common mechanisms in regulating host immunity pathways. For example, all 3C pro s from CVB3, EV-A71, and SSV cleave TRIF. However, occasionally homologous enzymes exhibit some unique characteristics; thus, the DENV but not the JEV NS2B/NS3 protease can cleave MFNs. All these findings not only contribute to our understanding of the host's immune response to viral infection but can also help us discover broad-spectrum or specific antiviral drugs targeting viral proteases and their interaction with host signaling pathways. Cleavage of the adaptor protein TRIF by enterovirus
